CITED4 anticorps (full length, N-Term)

N° du produit ABIN363240

Détail du produit anti-CITED4 anticorps

Antigène: CITED4 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 4 (CITED4))

Épitope: full length, N-Term

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CITED4 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunoprecipitation (IP)

Specificité: Reacts with human CITED4 protein

Réactivité croisée: Souris

Réactivité croisée (Details): Does not work well on mouse. Not tested in other species .

Purification: Purified

Immunogène: N-terminal fusion protein to full-length human CITED4

Clone: HT13-2D6-3

Isotype: IgG1 kappa

Information d'application

Indications d'application:

Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- ELISA : 1/100 to 1/1 000 - IF : 1/100 to 1/1 000 - IP : 1/100 to 1/1 000 - WB : 1/100 to 1/1 000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Tris-glycine, NaCl 150 mM buffer, Sodium azide 0.05 %

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C/-80 °C

Stockage commentaire: Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.

Détails sur CITED4

Antigène: CITED4 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 4 (CITED4))

Autre désignation: Cbp/p300-Interacting Transactivator 4 (CITED4 Produits)

Synonymes: anticorps CITED4, anticorps MRG-2, anticorps Mrg2, anticorps CITED3, anticorps cCITED3, anticorps similar to Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal, anticorps Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4, anticorps Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 4, anticorps Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 4 L homeolog, anticorps Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4, anticorps CITED4, anticorps cited4, anticorps cited4.L, anticorps Cited4